Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction
- 1 November 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (9) , 1113-1117
- https://doi.org/10.1016/j.amjcard.2004.07.075
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarctionJournal of the American College of Cardiology, 2003
- Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial InfarctionCirculation, 2002
- TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at PresentationCirculation, 2000
- Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic DrugsCirculation, 2000
- Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation, 1999
- Relationship Between TIMI Frame Count and Clinical Outcomes After Thrombolytic AdministrationCirculation, 1999
- TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial InfarctionCirculation, 1998
- TNK-Tissue Plasminogen Activator in Acute Myocardial InfarctionCirculation, 1997
- Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trialJournal of the American College of Cardiology, 1994
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985